Daxor Corporation DXR
8.46 USD -0.06 (-0.70%)
At closeNov 12, 2026, 4:00 PM EST
8.36 -0.10 -1.18%
After hours · Nov 12, 4:00 PM ET
8.24 Day range 8.56
8.24 52-week range 14.76
- YTD
- -42.64%
- 1 year
- -33.91%
News
defenseworld.net Daxor Corporation (NASDAQ:DXR) Shares Shorted: Short Interest Down 51.5% in October Daxor Corporation (NASDAQ: DXR - Get Free Report) was the target of a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 3,374 shares, a drop…
globenewswire.com Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26 FDA-cleared BVA™ technology delivers lab-accurate precision to optimize cardiovascular service lines, reduce 30-day readmissions, and lower cost of care. Key Highlights: Commercial Acceleration:…
benzinga.com Daxor Announces New Clinical Studies Validate BVA Technology In High-Acuity Heart Failure Populations To Enhance Care At HFSA 2026 Annual Scientific Meeting Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announced significant clinician interest and compelling clinical validation following the Heart Failure…
globenewswire.com Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026 New Clinical Studies Validate BVA™ Technology in High-Acuity Heart Failure Populations to Enhance Care OAK RIDGE, TN, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global…
globenewswire.com Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026 Making its ASN debut, Daxor's BVA™ technology delivers precise volume measurement to optimize fluid management and improve complex kidney care. Key Highlights: Commercial Presence: Daxor exhibiting…
defenseworld.net Daxor Corporation (NASDAQ:DXR) Sees Large Growth in Short Interest Daxor Corporation (NASDAQ: DXR - Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 6,959…
globenewswire.com Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026 FDA 510(k)-cleared next-generation diagnostic platform delivers 3x faster results with 50% less blood, setting a new standard for data-driven heart failure management. Key Highlights: Commercial…
globenewswire.com Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference Oak Ridge, TN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh…
globenewswire.com Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter Oak Ridge, TN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update…
globenewswire.com Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas Commercial Momentum Accelerates as Health System Adopts Turnkey Blood Volume Analysis via CLIA-Certified Send-Out Model OAK RIDGE, TN, July 29, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:…
globenewswire.com Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas Daxor to Showcase How BVA Provides the Objective Plasma and Red Blood Cell Data Needed to Target Dysautonomia Therapy Oak Ridge, TN, July 07, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR),…
globenewswire.com Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor New Technology Expands Daxor's Diagnostic Capabilities to Enable Continuous, Remote Tracking of Blood Volume Status Using Wearable Sensors, Enhancing Care for Heart Failure, Syncope, Anemia, and…
globenewswire.com Daxor Leverages MedAxiom CV Transforum Spring'26 to Accelerate Commercial Adoption of Blood Volume Analysis Oak Ridge, TN, April 28, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will exhibit its Blood Volume Analyzer…
globenewswire.com Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a new…
globenewswire.com Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the…
globenewswire.com Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions Oak Ridge, TN, March 17, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces its participation as an exhibitor at the…
seekingalpha.com Daxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Prepared Remarks Transcript Daxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Prepared Remarks Transcript
globenewswire.com Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak Ridge, TN, March 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in…
globenewswire.com Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 Oak Ridge, TN, March 09, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces that CEO and President Michael Feldschuh will…
globenewswire.com Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share Strategic Realignment to Clinical Growth Supported by FDA 510(k) Clearance for Next-Generation Blood Volume Analyzer Oak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR),…
benzinga.com 64 Biggest Movers From Friday Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM System for up to 180 days.…
benzinga.com Stocks That Hit 52-Week Lows On Friday Before 10 a.m. ET Friday, 62 stocks made new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday morning, 38 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday On Wednesday, 111 companies set new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Thursday This morning 168 companies reached new 52-week highs.- benzinga.com 85 Biggest Movers From Yesterday
- benzinga.com 50 Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com 108 Biggest Movers From Yesterday
benzinga.com Mid-Day Market Update: Crude Oil Rises Over 3%; Novavax Shares Plunge 
benzinga.com 55 Stocks Moving In Monday's Mid-Day Session - benzinga.com 88 Biggest Movers From Yesterday
- benzinga.com 70 Stocks Moving In Wednesday's Mid-Day Session
- benzinga.com 82 Biggest Movers From Yesterday
- benzinga.com 64 Biggest Movers From Yesterday